215 related articles for article (PubMed ID: 28915942)
1. Development of a validated LC- MS/MS method for the quantification of 19 endogenous asthma/COPD potential urinary biomarkers.
Khamis MM; Adamko DJ; El-Aneed A
Anal Chim Acta; 2017 Oct; 989():45-58. PubMed ID: 28915942
[TBL] [Abstract][Full Text] [Related]
2. Development of a new quantification method for organic acids in urine as potential biomarkers for respiratory illness.
Awad H; Allen KJH; Adamko DJ; El-Aneed A
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():29-38. PubMed ID: 31141761
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach.
Khamis MM; Adamko DJ; Purves RW; El-Aneed A
Anal Chim Acta; 2019 Jan; 1047():81-92. PubMed ID: 30567667
[TBL] [Abstract][Full Text] [Related]
4. Comparison of accuracy and precision between multipoint calibration, single point calibration, and relative quantification for targeted metabolomic analysis.
Khamis MM; Klemm N; Adamko DJ; El-Aneed A
Anal Bioanal Chem; 2018 Sep; 410(23):5899-5913. PubMed ID: 30006724
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.
Khamis MM; Holt T; Awad H; El-Aneed A; Adamko DJ
Metabolomics; 2018 Aug; 14(9):115. PubMed ID: 30830407
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.
Adamko DJ; Nair P; Mayers I; Tsuyuki RT; Regush S; Rowe BH
J Allergy Clin Immunol; 2015 Sep; 136(3):571-580.e3. PubMed ID: 26152317
[TBL] [Abstract][Full Text] [Related]
7. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
[TBL] [Abstract][Full Text] [Related]
8. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome.
Guo K; Li L
Anal Chem; 2009 May; 81(10):3919-32. PubMed ID: 19309105
[TBL] [Abstract][Full Text] [Related]
9. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
10. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the human biomonitoring of non-occupational exposure to the fragrance 2-(4-tert-butylbenzyl)propionaldehyde (lysmeral).
Pluym N; Krnac D; Gilch G; Scherer M; Leibold E; Scherer G
Anal Bioanal Chem; 2016 Aug; 408(21):5873-5882. PubMed ID: 27370687
[TBL] [Abstract][Full Text] [Related]
11. A novel diagnostic in situ derivatization kit for the simultaneous determination of 14 biomarkers of exposure to benzene, toluene, ethyl benzene and xylenes in human urine by isotope dilution liquid chromatography tandem mass spectrometry and kit optimization using response surface methodology.
Baghdady YZ; Schug KA
Anal Chim Acta; 2018 Dec; 1036():195-203. PubMed ID: 30253832
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS.
Shih YM; Cooke MS; Pan CH; Chao MR; Hu CW
Redox Biol; 2019 Jan; 20():556-565. PubMed ID: 30508700
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
14. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to measure creatinine in human urine.
Fraselle S; De Cremer K; Coucke W; Glorieux G; Vanmassenhove J; Schepers E; Neirynck N; Van Overmeire I; Van Loco J; Van Biesen W; Vanholder R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():88-97. PubMed ID: 25756209
[TBL] [Abstract][Full Text] [Related]
16. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of four metabolites of sulfur mustard in urine samples by ultra-high performance liquid chromatography-tandem mass spectrometry after solid phase extraction.
Liu CC; Liu SL; Xi HL; Yu HL; Zhou SK; Huang GL; Liang LH; Liu JQ
J Chromatogr A; 2017 Apr; 1492():41-48. PubMed ID: 28284764
[TBL] [Abstract][Full Text] [Related]
18. Automated parallel derivatization of metabolites with SWATH-MS data acquisition for qualitative and quantitative analysis.
Cifuentes Girard MF; Ruskic D; Böhm G; Picenoni R; Hopfgartner G
Anal Chim Acta; 2020 Aug; 1127():198-206. PubMed ID: 32800124
[TBL] [Abstract][Full Text] [Related]
19. Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review.
Higashi T; Ogawa S
J Pharm Biomed Anal; 2016 Oct; 130():181-193. PubMed ID: 27178301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
